A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
Clinical trial NCT07235462 · RECRUITING
Trial details
- NCT number
- NCT07235462
- Sponsor
- Bayer
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-10-29
- Primary completion
- 2028-04-30
- Enrollment
- 2000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.